Get daily global pharma news including pharmaceutical industry updates, drug approvals, biotech trends, healthcare innovations, and regulatory news.
Roche Launches AXELIOS 1: How SBX Technology Could Transform DNA Sequencing and Genomics Research
Roche has launched AXELIOS 1, a next-generation DNA sequencing platform powered by SBX technology. Discover its features, how it compares to existing sequencing systems, and what it means for genomics, clinical research, and pharma careers.
Drug Discovery Services Market to Reach US$67.3 Billion by 2035: How AI, CROs, and Biotech Are Reshaping Pharma R&D
The global drug discovery services market is expected to grow to US$67.3 billion by 2035. Discover how AI, CROs, biologics, and outsourcing are transforming pharmaceutical R&D and creating new career opportunities.
EC Approves Padcev + Keytruda for Resectable Muscle-Invasive Bladder Cancer in Europe
The European Commission has approved Padcev plus Keytruda as perioperative treatment for adults with resectable muscle-invasive bladder cancer who are ineligible for cisplatin chemotherapy.
AbbVie Gets European Commission Approval for Skyrizi in Children With Plaque Psoriasis
AbbVie has received European Commission approval for Skyrizi (risankizumab) to treat children and adolescents aged six years and older with moderate to severe plaque psoriasis who are candidates for systemic therapy.
-1782201163918-947677154.jpg)
AbbVie to Acquire Apogee Therapeutics for $10.9 Billion: A Major Immunology and Asthma Pipeline Bet
AbbVie plans to acquire Apogee Therapeutics for approximately $10.9 billion, strengthening its immunology pipeline in atopic dermatitis and asthma through long-acting antibody candidates including zumilokibart and APG273.
Johnson & Johnson MEMBRANE Trial Shows Positive Results for Chronic Subdural Hematoma Treatment
Johnson & Johnson’s MEMBRANE trial found that middle meningeal artery embolization with TRUFILL n-BCA plus standard care reduced chronic subdural hematoma recurrence and re-intervention compared with standard care alone.
-1781934369317-941754662.jpg)
Chiesi Showcases New Lipodystrophy Research at ENDO 2026: Expanding Understanding of Rare Metabolic Disorders
Chiesi Global Rare Diseases presented new metreleptin research at ENDO 2026, highlighting treatment outcomes, mental health challenges, and emerging care approaches for patients living with lipodystrophy.
The Rise of AI Knowledge Graphs in Pharma R&D: Why Connected Intelligence Is Becoming the Industry's Biggest Competitive Advantage
AI knowledge graphs are transforming pharmaceutical R&D by connecting scientific, clinical, regulatory, and real-world data. Discover how pharma companies are using AI-powered knowledge ecosystems to accelerate drug discovery, improve decision-making, and create future-ready careers.
Sun Pharma's Osteoarthritis Drug Receives USFDA Fast Track Status: A Major Innovation Milestone for Indian Pharma
Sun Pharma and Moebius Medical have received USFDA Fast Track designation for MM-II, a novel non-opioid treatment for osteoarthritis knee pain. Explore the significance, industry impact, and career opportunities arising from this breakthrough.
Ajanta Pharma in Focus After Major Stake Sale: What It Signals for Investors, the Pharma Industry, and Job Seekers
Ajanta Pharma has come under the spotlight after a promoter entity sold nearly 3% stake worth over ₹1,000 crore. Explore what this transaction means for investor confidence, the Indian pharmaceutical sector, and pharma professionals.
FDA Calendar Packed with Major Decisions: Key Pharmaceutical Approvals to Watch in 2026
The FDA's 2026 calendar is packed with major drug approval decisions across oncology, obesity, rare diseases, and neuroscience. Explore the biggest upcoming FDA decisions, their industry impact, and what they mean for pharma professionals.
What Holds the Future of Pharma in the Middle East? Market Growth, Pharma Jobs, Manufacturing & Innovation Outlook 2030
Discover the future of the pharmaceutical industry in the Middle East, including market growth, local manufacturing, biologics, regulatory transformation, investment trends, and emerging pharma job opportunities for professionals across India and the GCC.
The Growing Need for Structured Senior Health Financing in India: How Ageing Care Demands Are Reshaping Healthcare & Pharma Jobs
India’s ageing population is creating urgent demand for structured senior healthcare financing, geriatric care infrastructure, insurance innovation, and healthcare workforce expansion. Explore industry trends, pharma hiring opportunities, and future healthcare transformation.
Global Nurse Shortage 2026: How Nurses Are Transforming Patient Safety, Digital Healthcare & Pharma Careers
Amid the global nurse shortage in 2026, nurses are playing a larger role in patient safety, digital healthcare, pharma operations, and patient engagement. Explore career opportunities, healthcare trends, and future nursing roles shaping India’s healthcare ecosystem.
NITK Researchers Develop Antimicrobial Coating for Orthopaedic Implants: A Breakthrough for India’s Medical Device & Pharma Industry
NITK researchers have developed an advanced antimicrobial coating for orthopaedic implants that may reduce infection risks and improve implant safety. Explore its impact on India’s pharmaceutical, biotech, and medical device sectors.
China Pharma Industry Remains Resilient Amid Regulatory Scrutiny on Sensitive Tech Deals | Global Pharma Jobs Insights
Explore how the China pharma industry continues to stay resilient despite Beijing’s scrutiny on sensitive tech deals. Learn global pharma hiring trends, biotech investment outlook, and career opportunities with Big Pharma Jobs.
Pharmaceutical Manufacturing in Space: How BioOrbit Is Transforming Cancer Drug Delivery
Discover how UK biotech startup BioOrbit is using space-based pharmaceutical manufacturing and microgravity crystallization to develop self-injectable cancer drugs and revolutionize global healthcare.
AI in Pharma R&D: How Artificial Intelligence is Transforming Drug Discovery, Clinical Trials & Precision Medicine
AI in pharma R&D is revolutionizing drug discovery, clinical trials, and precision medicine. Learn how global pharmaceutical companies are using AI to speed up innovation and reduce development costs.
CVC & GBL’s €10.7 Billion Recordati Deal: What Europe’s Biggest Pharma Acquisition Means for the Global Pharmaceutical Industry in 2026
Explore the €10.7 billion Recordati acquisition by CVC Capital Partners and GBL. Discover how this major pharma M&A deal is reshaping rare disease markets, specialty pharma, global healthcare investments, and pharmaceutical careers in 2026.
Global Pharma News | Daily Pharmaceutical Industry Updates
Stay updated with the latest global pharma news, pharmaceutical industry developments, AI healthcare innovations, regulatory updates, drug manufacturing trends, biotech investments, and worldwide pharma hiring insights.
Roche Launches AXELIOS 1: How SBX Technology Could Transform DNA Sequencing and Genomics Research
Roche has launched AXELIOS 1, a next-generation DNA sequencing platform powered by SBX technology. Discover its features, how it compares to existing sequencing systems, and what it means for genomics, clinical research, and pharma careers.
Drug Discovery Services Market to Reach US$67.3 Billion by 2035: How AI, CROs, and Biotech Are Reshaping Pharma R&D
The global drug discovery services market is expected to grow to US$67.3 billion by 2035. Discover how AI, CROs, biologics, and outsourcing are transforming pharmaceutical R&D and creating new career opportunities.
EC Approves Padcev + Keytruda for Resectable Muscle-Invasive Bladder Cancer in Europe
The European Commission has approved Padcev plus Keytruda as perioperative treatment for adults with resectable muscle-invasive bladder cancer who are ineligible for cisplatin chemotherapy.
AbbVie Gets European Commission Approval for Skyrizi in Children With Plaque Psoriasis
AbbVie has received European Commission approval for Skyrizi (risankizumab) to treat children and adolescents aged six years and older with moderate to severe plaque psoriasis who are candidates for systemic therapy.
